Treatment of Hidradenitis Suppurativa With 755-nm Alexandrite Laser Hair Removal: A Randomized Controlled Trial.
Document Type
Article
Publication Date
9-2024
Publication Title
JAAD International
Abstract
BACKGROUND: Hidradenitis supprativa is a chronic inflammatory skin disease that can respond to treatment with laser hair removal.
OBJECTIVE: To assess alexandrite laser hair removal laser as a treatment for hidradenitis suppurativa as measured by the Hidradenitis Supprativa Clinical Response.
MATERIALS AND METHODS: We conducted a prospective, randomized, controlled study in adult patients with hidradenitis supprativa. Participants underwent a series of 4 monthly laser treatments to 1 side of the body, with the contralateral side serving as a control. The primary outcome was Hidradenitis Supprativa Clinical Response at week 24, 8 weeks after the final laser treatment.
RESULTS: The percent improvement across treated sites after 4 treatments was 72.73% axillary, 70% inguinal, and 100% inframammary. Across all body regions, Hidradenitis Supprativa Clinical Response was significantly higher for the sites treated with the alexandrite laser compared to the contralateral controls: 75% vs 33.33% (
LIMITATIONS: The limitations of this study include a small sample size from which the data was collected.
CONCLUSIONS: The 775-nm alexandrite laser is a safe and effective treatment for hidradenitis supprativa at various anatomic sites in both resolving preexisting lesions and preventing new eruptions.
Volume
16
First Page
239
Last Page
243
Recommended Citation
Sidhom S, Petry SU, Ward R, Daveluy S. Treatment of hidradenitis suppurativa with 755-nm alexandrite laser hair removal: a randomized controlled trial. JAAD Int. 2024 Apr 24;16:239-243. doi: 10.1016/j.jdin.2024.04.005. PMID: 39072264.
DOI
10.1016/j.jdin.2024.04.005
ISSN
2666-3287
PubMed ID
39072264